Client’s Testimonial:
“Very great news!!! Thank you very much [for] your kind help and continuous assistance.”
On March 3rd, 2016, we received another EB-2 NIW (National Interest Waiver) approval for a Senior Research Associate in the Field of Pharmaceutical Chemistry (Approval Notice).
General Field: Pharmaceutical Chemistry
Position at the Time of Case Filing: Senior Research Associate
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: North Carolina
Approval Notice Date: March 3rd, 2016
Processing Time: 8 months, 3 days
Case Summary:
A talented senior research associate engaged the legal services of North America Immigration Law Group to file an EB-2 NIW (National Interest Waiver) petition on his behalf. Our client is working in the field of pharmaceutical chemistry and has years of experience researching novel treatments for cancer.
His advanced degrees (M.Sc. in Pharmacy and Ph.D. in Pharmaceutical Sciences and Chemistry) have equipped him with the skills and knowledge needed to conduct outstanding investigations in the field. We demonstrated that his work advances the United States’ medical research industry and the understanding of how to develop better cancer treatments. Furthermore, our EB-2 NIW petition packet highlighted the value of his findings to the country’s public health and economy—in the form of savings in health care costs.
“Advancements in the field of cancer research require the skills of top researchers. [Client], throughout his studies, has shown himself to be a scientist devoted to creating innovations in cancer therapies.”
This statement is excerpted from a recommendation letter contributed by a prominent research professor in the field. This letter, and the handful of others that we obtained from other influential pharmaceutical chemists, supported our argument that our client’s work is essential to not just the field, but to all Americans.
“He also received a large number of citations from domestic and international scientists – to be exact, his citation count totals about 600. This is an outstanding citation count that firmly testifies to [Client's] status as an elite, respected researcher in our shared field of specialization.”
To be more specific, our client’s 35 published papers had gathered 654 citations at the time of filing. This impressive record is a clear indication of his talents as a pharmaceutical scientist, and that many others in the field are heavily dependent on his work to progress their own research efforts.
Our firm presentation of our client’s outstanding capabilities as a researcher in the field and his strong credentials lent a hand in garnering an approval notice from the USCIS. We congratulate our client on this achievement, and we wish him the best with the final step in the green card process: the I-485 application.